HCQ (IMAGE)
Caption
A new trial will evaluate whether the drug hydroxychloroquine (HCQ) can benefit people infected with COVID-19, as well as whether taking the drug preventatively may help people avoid infection altogether.
Credit
Penn Medicine
Usage Restrictions
None
License
Licensed content